Changes of mortality for special causes of death in β2-microglobulin positive and negative subjects
| Men | Women | ||||||
|---|---|---|---|---|---|---|---|
| β2-MG | Death | Hazard ratio | (95% CI) | Death | Hazard ratio | (95% CI) | |
| β2-MG(−), urinary β2-microgrobulin <1000 μg/gCr; β2-MG(+), urinary β2-microgrobulin ⩾1000 μg/gCr; NS, not significant. | |||||||
| *p<0.05; **p<0.01, ***p<0.001. | |||||||
| All causes | |||||||
| 5 years (−1986) | − | 86 | 1 | 64 | 1 | ||
| + | 58 | 1.83 | (1.27–2.62)*** | 66 | 1.79 | (1.23–2.61)** | |
| 10 years (−1991) | − | 216 | 1 | 164 | 1 | ||
| + | 104 | 1.61 | (1.25–2.07)*** | 145 | 1.82 | (1.43–2.33)*** | |
| 15 years (−1996) | − | 367 | 1 | 271 | 1 | ||
| + | 140 | 1.56 | (1.27–1.92)*** | 199 | 1.86 | (1.53–2.27)*** | |
| Malignant neoplasms | |||||||
| 5 years (–1986) | − | 24 | 1 | 14 | 1 | ||
| + | 7 | 0.95 | (0.39–2.33) NS | 10 | 2.57 | (1.03–6.43)* | |
| 10 years (–1991) | − | 63 | 1 | 27 | 1 | ||
| + | 14 | 0.84 | (0.46–1.55) NS | 21 | 2.89 | (1.52–5.48)** | |
| 15 years (–1996) | − | 103 | 1 | 59 | 1 | ||
| + | 24 | 1.12 | (0.75–1.92) NS | 24 | 1.63 | (0.97–2.74) NS | |
| Heart failure | |||||||
| 5 years (–1986) | − | 7 | 1 | 7 | 1 | ||
| + | 8 | 2.16 | (0.64–6.34) NS | 14 | 2.4 | (0.8–6.58) NS | |
| 10 years (–1991) | − | 22 | 1 | 30 | 1 | ||
| + | 20 | 2.7 | (1.41–5.15)** | 34 | 1.83 | (1.08–3.08)* | |
| 15 years (–1996) | − | 38 | 1 | 41 | 1 | ||
| + | 22 | 1.92 | (1.10–3.35)* | 46 | 2.16 | (1.88–3.37)** | |
| Cerebral infarction | |||||||
| 5 years (–1986) | − | 8 | 1 | 7 | 1 | ||
| + | 11 | 2.78 | (1.02–7.60)* | 12 | 2.4 | (0.87–6.58)NS | |
| 10 years (–1991) | − | 22 | 1 | 15 | 1 | ||
| + | 20 | 3.66 | (1.36–9.88)* | 23 | 2.42 | (1.20–4.87)* | |
| 15 years (–1996) | − | 31 | 1 | 23 | 1 | ||
| + | 28 | 3.34 | (1.92–5.80)*** | 31 | 2.64 | (1.48–4.71)** | |
| Digestive diseases | |||||||
| 5 years (–1986) | − | 7 | 1 | 4 | 1 | ||
| + | 5 | 2.31 | (0.66–8.15) NS | 3 | 0.91 | (0.19–4.48) NS | |
| 10 years (–1991) | − | 12 | 1 | 11 | 1 | ||
| + | 7 | 2.45 | (0.88–6.80)* | 10 | 1.62 | (0.64–4.06)NS | |
| 15 years (–1996) | − | 17 | 18 | 1 | |||
| + | 8 | 2.6 | (1.04–6.51)* | 14 | 1.88 | (0.89–3.99) NS | |
| Nephritis and nephrosis | |||||||
| 5 years (–1986) | − | 0 | – | – | 1 | – | – |
| + | 3 | – | – | 0 | – | – | |
| 10 years (–1991) | − | 4 | 1 | 2 | 1 | ||
| + | 5 | 3.29 | (0.82–13.3)* | 3 | 2.63 | (0.39–17.8) NS | |
| 15 years (–1996) | − | 7 | 1 | 3 | 1 | ||
| + | 10 | 5.66 | (2.01–16.0)** | 8 | 7.31 | (1.78–30.1)*** | |